Further, we systemically evaluated the effect of 150 nM Am80, the plasma concentration dose nearly reaching the routine clinical usage of Am80 for APL (Appendix Table S1A), on inducing functional neutrophils when combined with GCSF. The gene discussed is CSF3; the disease is acute promyelocytic leukemia.